| Genomic analyses identify molecular subtypes of pancreatic cancer P Bailey, DK Chang, K Nones, AL Johns, AM Patch, MC Gingras, ... Nature 531 (7592), 47-52, 2016 | 3512 | 2016 |
| Heterogeneous nuclear ribonucleoprotein H blocks MST2-mediated apoptosis in cancer cells by regulating A-Raf transcription J Rauch, E O'Neill, B Mack, C Matthias, M Munz, W Kolch, O Gires Cancer research 70 (4), 1679-1688, 2010 | 183* | 2010 |
| Heterogeneous nuclear ribonucleoprotein A3, a novel RNA trafficking response element-binding protein ASW Ma, K Moran-Jones, J Shan, TP Munro, MJ Snee, KS Hoek, R Smith Journal of Biological Chemistry 277 (20), 18010-18020, 2002 | 140 | 2002 |
| Targeting DNA damage response and replication stress in pancreatic cancer SB Dreyer, R Upstill-Goddard, V Paulus-Hock, C Paris, EM Lampraki, ... Gastroenterology 160 (1), 362-377. e13, 2021 | 126 | 2021 |
| hnRNP A2, a potential ssDNA/RNA molecular adapter at the telomere K Moran-Jones, L Wayman, DD Kennedy, RR Reddel, S Sara, MJ Snee, ... Nucleic acids research 33 (2), 486-496, 2005 | 116 | 2005 |
| HNF4A and GATA6 loss reveals therapeutically actionable subtypes in pancreatic cancer H Brunton, G Caligiuri, R Cunningham, R Upstill-Goddard, UM Bailey, ... Cell reports 31 (6), 2020 | 113 | 2020 |
| Australian Pancreatic Cancer Genome I P Bailey, DK Chang, K Nones, AL Johns, AM Patch, MC Gingras, ... Munzy DM, Fisher WE, Karim SA, Eshleman JR, Hruban RH, Pilarsky C, Morton JP …, 2016 | 98 | 2016 |
| hnRNP A2 regulates alternative mRNA splicing of TP53INP2 to control invasive cell migration K Moran-Jones, J Grindlay, M Jones, R Smith, JC Norman Cancer research 69 (24), 9219-9227, 2009 | 92 | 2009 |
| Binding of an RNA trafficking response element to heterogeneous nuclear ribonucleoproteins A1 and A2 J Shan, K Moran-Jones, TP Munro, GJ Kidd, DJ Winzor, KS Hoek, R Smith Journal of Biological Chemistry 275 (49), 38286-38295, 2000 | 77 | 2000 |
| Precision oncology in surgery: patient selection for operable pancreatic cancer SB Dreyer, M Pinese, NB Jamieson, CJ Scarlett, EK Colvin, M Pajic, ... Annals of surgery 272 (2), 366-376, 2020 | 65 | 2020 |
| VEGFR1 (Flt1) regulates Rab4 recycling to control fibronectin polymerization and endothelial vessel branching MC Jones, PT Caswell, K Moran‐Jones, M Roberts, ST Barry, A Gampel, ... Traffic 10 (6), 754-766, 2009 | 53 | 2009 |
| ZNF300P1 Encodes a lincRNA that regulates cell polarity and is epigenetically silenced in type II epithelial ovarian cancer B Gloss, K Moran-Jones, V Lin, M Gonzalez, J Scurry, NF Hacker, ... Molecular cancer 13, 1-10, 2014 | 46 | 2014 |
| βIV tubulin is selectively expressed by oligodendrocytes in the central nervous system N Terada, GJ Kidd, M Kinter, C Bjartmar, K Moran‐Jones, BD Trapp Glia 50 (3), 212-222, 2005 | 41 | 2005 |
| Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer K Moran-Jones, BS Gloss, R Murali, DK Chang, EK Colvin, MD Jones, ... Oncotarget 6 (42), 44551, 2015 | 40 | 2015 |
| FAK deletion promotes p53-mediated induction of p21, DNA-damage responses and radio-resistance in advanced squamous cancer cells K Graham, K Moran-Jones, OJ Sansom, VG Brunton, MC Frame PLoS One 6 (12), e27806, 2011 | 39 | 2011 |
| INC280, an orally available small molecule inhibitor of c-MET, reduces migration and adhesion in ovarian cancer cell models K Moran-Jones, LM Brown, G Samimi Scientific Reports 5 (1), 11749, 2015 | 29 | 2015 |
| b1 integrin deletion enhances progression of prostate cancer in the TRAMP mouse model K Moran-Jones, A Ledger, M Naylor Scientific Reports 2, 2012 | 25 | 2012 |
| Molecular recognition of an RNA trafficking element by heterogeneous nuclear ribonucleoprotein A2 MJ Landsberg, K Moran-Jones, R Smith Biochemistry 45 (12), 3943-3951, 2006 | 19 | 2006 |
| The therapeutic potential of targeting the HGF/cMET axis in ovarian cancer K Moran-Jones Molecular diagnosis & therapy 20 (3), 199-212, 2016 | 11 | 2016 |
| Pharmacologic Targeting of TFIIH Suppresses KRAS-Mutant Pancreatic Ductal Adenocarcinoma and Synergizes with TRAIL R Moser, J Annis, O Nikolova, C Whatcott, K Gurley, E Mendez, ... Cancer research 82 (18), 3375-3393, 2022 | 3 | 2022 |
Trent MunroThe University of QueenslandVerified email at uq.edu.au